Oxygen Concentrators Market Strategies, Market Opportunities, and Market Forecasts
Pages: 121
Publisher: WinterGreen Research
Date Published: January 2002
Format: PDF
Price: $2800
Overview
Oxygen Concentrators Markets,
Treatment Trends,
U.S. Healthcare Delivery Industry,
Market Drivers For Healthcare Cost Containmen,t
Homecare Market Growth Factors,
Homecare Information Systems Market Trends,
Home Medical Information Systems Market Segments,
Oxygen Concentrator Market Shares,
MARKET FORECASTS TO 2007
Oxygen concentrators market strategies, Market Opportunities, market forecasts, 2002-2007
Many medical professionals and patients prefer home health care to institutional care because they believe that it results in greater patient independence, increased patient responsibility, and improved responsiveness to treatment. Familiar surroundings are believed to be conducive to improved patient outcomes.
Health care professionals, public payors, and private payors agree that home care is a cost effective, clinically appropriate alternative to facility-based care. Adults would rather recover from accident or illness in their home. Many studies show that over 90% of the older population prefers home-based long-term care.
Patient preference for home healthcare is universal. Oxygen concentrators provide quality of life in a homecare setting.
The worldwide standard oxygen concentrator market, which was at $300,161 million in the year 2001, is expected to grow steadily over the next few years and reach $377,878 million by the year 2007.
Oxygen concentrator products enrich normal room air to a 90% oxygen level for patients suffering from chronic obstructive lung diseases such as emphysema and bronchitis. Oxygen concentrators provide a continuous flow of oxygen by separating oxygen from room air with a molecular sieve composed of an inorganic silicate. Units from a range of different manufacturers use compressors from the same manufacturer, Thomas.
Oxygen concentrators are generally used in the home by patients who require supplemental oxygen. Supplemental oxygen is prescribed for people with a variety of chronic pulmonary disorders, such as lung cancer, emphysema, bronchitis or acute pneumonia.
Companies ProfiledMarket Leaders
AirSep
CHAD Therapeutics
Invacare Corporation
Mada
OxLife
Respironics
SeQual Technologies
Sievetek
Sunrise Medical
Thomas Industries
UOP
